| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
62,894,000 |
| Market
Cap: |
2.22(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.61 - $51.88 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
246,388 |
246,388 |
246,388 |
470,243 |
| Total Sell Value |
$8,325,092 |
$8,325,092 |
$8,325,092 |
$16,684,033 |
| Total People Sold |
6 |
6 |
6 |
9 |
| Total Sell Transactions |
7 |
7 |
7 |
15 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Keler Tibor |
Executive VP & CSO |
• – – |
2016-09-02 |
4 |
B |
$3.32 |
$9,960 |
D/D |
3,000 |
18,868 |
2.74 |
- |
|
| Crowley Elizabeth |
SVP, Chief Product Dev Officer |
• – – |
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,322 |
|
- |
|
| Elston George |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
28,500 |
|
- |
|
| Van Den Broek Richard |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
233,500 |
|
- |
|
| Conrad Herbert J |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
28,500 |
|
- |
|
| Lipton Karen Shoos |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,833 |
|
- |
|
| Ellberger Larry |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
63,500 |
|
- |
|
| Penner Harry Jr |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,916 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2016-06-03 |
4 |
OE |
$2.80 |
$68,812 |
D/D |
22,847 |
73,586 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2016-03-09 |
4 |
OE |
$2.80 |
$42,000 |
D/D |
15,000 |
50,739 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2015-11-23 |
4 |
AS |
$18.00 |
$450,000 |
D/D |
(25,000) |
35,109 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2015-11-23 |
4 |
OE |
$8.52 |
$213,000 |
D/D |
25,000 |
60,109 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2015-09-11 |
4 |
OE |
$4.50 |
$45,000 |
D/D |
10,000 |
35,109 |
|
- |
|
| Ellberger Larry |
Director |
– • – |
2015-08-25 |
4 |
B |
$14.00 |
$70,000 |
D/D |
5,000 |
53,500 |
2.39 |
- |
|
| Ellberger Larry |
Director |
– • – |
2015-08-20 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
48,500 |
2.39 |
- |
|
| Ellberger Larry |
Director |
– • – |
2015-08-18 |
4 |
B |
$15.93 |
$79,747 |
D/D |
5,000 |
43,500 |
2.39 |
- |
|
| Marucci Anthony S |
President and CEO |
• • – |
2015-08-13 |
4 |
B |
$16.81 |
$97,497 |
D/D |
5,800 |
50,028 |
2.81 |
- |
|
| Ellberger Larry |
Director |
– • – |
2015-08-13 |
4 |
B |
$16.59 |
$82,950 |
D/D |
5,000 |
38,500 |
2.39 |
- |
|
| Wright Richard M. |
Sr. VP & CCOOfficer |
• – – |
2015-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,125 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2015-06-15 |
4 |
AS |
$24.59 |
$614,753 |
D/D |
(25,000) |
24,609 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2015-06-15 |
4 |
OE |
$8.52 |
$213,000 |
D/D |
25,000 |
49,609 |
|
- |
|
| Van Den Broek Richard |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
8,500 |
|
- |
|
| Elston George |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
18,500 |
|
- |
|
| Lipton Karen Shoos |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
21,833 |
|
- |
|
| Ellberger Larry |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
33,500 |
|
- |
|
255 Records found
|
|
Page 5 of 11 |
|
|
0.17 (0.48%) 
